From: Assessing amblyopia treatment using multifocal visual evoked potentials
Case | Sex | Refractive error(D) | BCVAa (At diagnosis) | BCVA (After treatment) | |||
---|---|---|---|---|---|---|---|
Amblyopic eye | Fellow eye | Amblyopic eye | Fellow eye | Amblyopic eye | Fellow eye | ||
1 | M | sph + 5.5 | sph + 0.75 | 20/30 | 20/20 | 20/20 | 20/20 |
2 | M | sph + 2.5,cyl + 1.5 | sph + 1.5 | 20/30 | 20/15 | 20/20 | 20/15 |
3 | M | sph + 4.5, cvl + 2.0 | sph + 3.5, cyl + 1.5 | 20/40 | 20/25 | 20/20 | 20/20 |
4 | F | sph + 0.5, cyl − 3.5 | sph + 0.25, cyl − 2.0 | 20/25 | 20/15 | 20/20 | 20/15 |
5 | F | sph + 4.0 | sph + 0.5 | 20/30 | 20/20 | 20/20 | 20/20 |
6 | M | sph + 5.5 | sph + 0.25 | 20/30 | 20/20 | 20/20 | 20/20 |
7 | F | sph + 3.0, cyl −1.0 | sph + 1.0 | 20/30 | 20/20 | 20/20 | 20/20 |
8 | F | sph + 2.0, cyl-4.5 | sph + 0.5 | 20/30 | 20/15 | 20/20 | 20/15 |
9 | F | sph + 5.0, cyl + 1.0 | sph + 3.0, cyl + 1.0 | 20/30 | 20/20 | 20/20 | 20/15 |
10 | F | sph + 1.5, cyl −2.5 | sph + 1.0 | 20/30 | 20/20 | 20/20 | 20/20 |
11 | F | sph + 4.5, cyl-6.0 | sph + 0.5 | 20/100 | 20/15 | 20/20 | 20/15 |
12 | F | sph + 1.0, cyl + 1.5 | sph + 1.25 | 20/40 | 20/20 | 20/20 | 20/20 |
13 | F | sph + 6.0 | sph + 2.0 | 20/30 | 20/20 | 20/20 | 20/20 |
14 | F | sph −1.75 | sph −0.5 | 20/30 | 20/20 | 20/20 | 20/20 |
15 | M | sph + 4.5 | sph + 1.0 | 20/40 | 20/15 | 20/20 | 20/15 |
16 | M | sph + 3.75 | sph + 2.75 | 20/70 | 20/20 | 20/20 | 20/20 |
17 | F | sph + 3.0, cyl −4.0 | sph + 2.25 | 20/30 | 20/15 | 20/20 | 20/15 |
18 | M | sph + 2.0 | sph + 0.25 | 20/50 | 20/20 | 20/20 | 20/20 |
19 | M | sph + 7.0 | sph + 5.0 | 20/50 | 20/20 | 20/20 | 20/20 |